Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On January 11, 2026, Nuvation Bio Inc. (the “Company”) entered into a License and Collaboration Agreement (the “Lice
Results of Operations and Financial Condition. On January 12, 2026, the Company issued a press release announcing, among other things, the Company’s preliminary
and in Exhibits 99.1, 99.2 and 99.3 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exc
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release of Nuvation Bio Inc. dated January 12, 2026. 99.2 Press Release of